Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.08567828 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.66068749 |
3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.66068749 |
4 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.65929595 |
5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.60739856 |
6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.49085207 |
7 | negative regulation of cell killing (GO:0031342) | 4.49085207 |
8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.34335181 |
9 | mannose metabolic process (GO:0006013) | 4.13517330 |
10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.05075497 |
11 | positive regulation of interferon-alpha production (GO:0032727) | 3.79974749 |
12 | macroautophagy (GO:0016236) | 3.79201131 |
13 | cellular response to virus (GO:0098586) | 3.74498323 |
14 | regulation of gamma-delta T cell activation (GO:0046643) | 3.73640815 |
15 | response to type I interferon (GO:0034340) | 3.72733355 |
16 | positive thymic T cell selection (GO:0045059) | 3.72206980 |
17 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.69846582 |
18 | regulation of interferon-alpha production (GO:0032647) | 3.57089325 |
19 | regulation of histone H3-K27 methylation (GO:0061085) | 3.49134753 |
20 | type I interferon signaling pathway (GO:0060337) | 3.49006219 |
21 | cellular response to type I interferon (GO:0071357) | 3.49006219 |
22 | response to peptidoglycan (GO:0032494) | 3.45376562 |
23 | regulation of early endosome to late endosome transport (GO:2000641) | 3.40888458 |
24 | regulation of RNA export from nucleus (GO:0046831) | 3.37924597 |
25 | Golgi transport vesicle coating (GO:0048200) | 3.37086088 |
26 | COPI coating of Golgi vesicle (GO:0048205) | 3.37086088 |
27 | protein targeting to Golgi (GO:0000042) | 3.32506679 |
28 | oxygen transport (GO:0015671) | 3.30832604 |
29 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.25360951 |
30 | establishment of protein localization to Golgi (GO:0072600) | 3.24914736 |
31 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.17667912 |
32 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.16421609 |
33 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.11684211 |
34 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.09862203 |
35 | nuclear pore complex assembly (GO:0051292) | 3.00635073 |
36 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.99241483 |
37 | positive regulation of histone deacetylation (GO:0031065) | 2.97819569 |
38 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.96301995 |
39 | positive T cell selection (GO:0043368) | 2.96065940 |
40 | gas transport (GO:0015669) | 2.95020150 |
41 | neutrophil activation involved in immune response (GO:0002283) | 2.94738421 |
42 | modulation by symbiont of host cellular process (GO:0044068) | 2.94374853 |
43 | erythrocyte maturation (GO:0043249) | 2.93918787 |
44 | thymic T cell selection (GO:0045061) | 2.93020593 |
45 | regulation of integrin activation (GO:0033623) | 2.88289940 |
46 | negative thymic T cell selection (GO:0045060) | 2.84343525 |
47 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.83780637 |
48 | iron ion import (GO:0097286) | 2.81767254 |
49 | positive regulation of B cell differentiation (GO:0045579) | 2.80817551 |
50 | negative T cell selection (GO:0043383) | 2.78973146 |
51 | modulation by virus of host process (GO:0019054) | 2.77903610 |
52 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.77657488 |
53 | regulation of necroptotic process (GO:0060544) | 2.77356983 |
54 | T cell selection (GO:0045058) | 2.77289652 |
55 | erythrocyte development (GO:0048821) | 2.76051766 |
56 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.74811314 |
57 | glucose 6-phosphate metabolic process (GO:0051156) | 2.73432210 |
58 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.72478929 |
59 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.71846299 |
60 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.71797434 |
61 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.70339073 |
62 | detection of other organism (GO:0098543) | 2.67105137 |
63 | detection of bacterium (GO:0016045) | 2.65774300 |
64 | germinal center formation (GO:0002467) | 2.65681262 |
65 | positive regulation of nuclease activity (GO:0032075) | 2.65133954 |
66 | regulation of response to osmotic stress (GO:0047484) | 2.62078517 |
67 | regulation of translational fidelity (GO:0006450) | 2.60527456 |
68 | regulation of mast cell degranulation (GO:0043304) | 2.60301900 |
69 | platelet formation (GO:0030220) | 2.59222257 |
70 | striated muscle atrophy (GO:0014891) | 2.57360523 |
71 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.55454167 |
72 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.52187392 |
73 | regulation of leukocyte degranulation (GO:0043300) | 2.52117077 |
74 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.51855821 |
75 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.51500198 |
76 | negative regulation of necroptotic process (GO:0060546) | 2.51073816 |
77 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.50486425 |
78 | skeletal muscle adaptation (GO:0043501) | 2.50467777 |
79 | definitive hemopoiesis (GO:0060216) | 2.50357330 |
80 | positive regulation of p38MAPK cascade (GO:1900745) | 2.50183643 |
81 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.49945634 |
82 | regulation of nuclease activity (GO:0032069) | 2.47532807 |
83 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.46988886 |
84 | response to thyroid hormone (GO:0097066) | 2.46587008 |
85 | myeloid cell development (GO:0061515) | 2.45466267 |
86 | cell-substrate junction assembly (GO:0007044) | 2.44876447 |
87 | growth hormone receptor signaling pathway (GO:0060396) | 2.44103569 |
88 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.43715758 |
89 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.43110473 |
90 | response to interleukin-15 (GO:0070672) | 2.42200682 |
91 | B cell receptor signaling pathway (GO:0050853) | 2.41578224 |
92 | embryonic process involved in female pregnancy (GO:0060136) | 2.41059320 |
93 | ER-nucleus signaling pathway (GO:0006984) | 2.39788601 |
94 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.39174404 |
95 | focal adhesion assembly (GO:0048041) | 2.37699699 |
96 | cell-substrate adherens junction assembly (GO:0007045) | 2.37699699 |
97 | cGMP-mediated signaling (GO:0019934) | 2.37627505 |
98 | positive regulation of interferon-beta production (GO:0032728) | 2.37240879 |
99 | cellular response to unfolded protein (GO:0034620) | 2.37042475 |
100 | regulation of ARF protein signal transduction (GO:0032012) | 2.36567398 |
101 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.34440326 |
102 | granulocyte differentiation (GO:0030851) | 2.33857779 |
103 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.33470750 |
104 | stress fiber assembly (GO:0043149) | 2.33111315 |
105 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.32685644 |
106 | response to laminar fluid shear stress (GO:0034616) | 2.32322375 |
107 | protein localization to endosome (GO:0036010) | 2.32318312 |
108 | regulation of T cell tolerance induction (GO:0002664) | 2.31955677 |
109 | regulation of platelet aggregation (GO:0090330) | 2.31838626 |
110 | hypotonic response (GO:0006971) | 2.31760632 |
111 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.30454684 |
112 | regulation of cholesterol homeostasis (GO:2000188) | 2.30121236 |
113 | positive regulation of receptor recycling (GO:0001921) | 2.30112591 |
114 | positive regulation of protein deacetylation (GO:0090312) | 2.30097799 |
115 | positive regulation of Rap GTPase activity (GO:0032854) | 2.29820141 |
116 | regulation of B cell differentiation (GO:0045577) | 2.28623725 |
117 | megakaryocyte development (GO:0035855) | 2.26727571 |
118 | negative regulation of viral release from host cell (GO:1902187) | 2.26272981 |
119 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.26081127 |
120 | adherens junction assembly (GO:0034333) | 2.24563792 |
121 | detection of external biotic stimulus (GO:0098581) | 2.23548885 |
122 | nuclear pore organization (GO:0006999) | 2.23466948 |
123 | regulation of ARF GTPase activity (GO:0032312) | 2.22125034 |
124 | NIK/NF-kappaB signaling (GO:0038061) | 2.21925318 |
125 | regulation of p38MAPK cascade (GO:1900744) | 2.21566775 |
126 | negative regulation of bone resorption (GO:0045779) | 2.21561612 |
127 | T cell migration (GO:0072678) | 2.19879736 |
128 | macrophage activation involved in immune response (GO:0002281) | 2.19078967 |
129 | regulation of cholesterol storage (GO:0010885) | 2.18641913 |
130 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.17905760 |
131 | cellular response to interferon-gamma (GO:0071346) | 2.17196359 |
132 | positive regulation by symbiont of host defense response (GO:0052509) | 2.17181779 |
133 | modulation by symbiont of host defense response (GO:0052031) | 2.17181779 |
134 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.17181779 |
135 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.17181779 |
136 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.17181779 |
137 | modulation by symbiont of host immune response (GO:0052553) | 2.17181779 |
138 | negative regulation of viral entry into host cell (GO:0046597) | 2.16567014 |
139 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.15852931 |
140 | thrombin receptor signaling pathway (GO:0070493) | 2.15239323 |
141 | activation of JUN kinase activity (GO:0007257) | 2.14950382 |
142 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.12651115 |
143 | cellular response to growth hormone stimulus (GO:0071378) | 2.12286553 |
144 | phospholipid dephosphorylation (GO:0046839) | 2.09297193 |
145 | natural killer cell differentiation (GO:0001779) | 2.09181813 |
146 | positive regulation of cytokine-mediated signaling pathway (GO:0001961) | 2.09064088 |
147 | muscle atrophy (GO:0014889) | 2.08784433 |
148 | response to muramyl dipeptide (GO:0032495) | 2.08745400 |
149 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.06245744 |
150 | positive regulation of phagocytosis (GO:0050766) | 2.05611887 |
151 | phospholipid homeostasis (GO:0055091) | 2.03187448 |
152 | regulation of viral entry into host cell (GO:0046596) | 2.02424930 |
153 | T cell costimulation (GO:0031295) | 2.01122957 |
154 | cortical actin cytoskeleton organization (GO:0030866) | 2.01116562 |
155 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.00842412 |
156 | regulation of regulatory T cell differentiation (GO:0045589) | 2.00483996 |
157 | regulation of erythrocyte differentiation (GO:0045646) | 2.00215790 |
158 | regulation of viral release from host cell (GO:1902186) | 1.99383398 |
159 | protein kinase C signaling (GO:0070528) | 1.98477454 |
160 | positive regulation of actin cytoskeleton reorganization (GO:2000251) | 1.97788772 |
161 | lymphocyte costimulation (GO:0031294) | 1.96937312 |
162 | I-kappaB phosphorylation (GO:0007252) | 1.96859953 |
163 | cytokine biosynthetic process (GO:0042089) | 1.96787531 |
164 | T-helper 1 type immune response (GO:0042088) | 1.96225148 |
165 | mucosal-associated lymphoid tissue development (GO:0048537) | 1.95758373 |
166 | Peyers patch development (GO:0048541) | 1.95758373 |
167 | angiogenesis involved in wound healing (GO:0060055) | 1.95161267 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.51165938 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.28292661 |
3 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.12402205 |
4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.07708948 |
5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.79949004 |
6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.54658142 |
7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.21534068 |
8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.15416407 |
9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.11151581 |
10 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.09825519 |
11 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.09091122 |
12 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.04143128 |
13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.03639182 |
14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.02904152 |
15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.00454807 |
16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.96902156 |
17 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.96493544 |
18 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.96027092 |
19 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.94981572 |
20 | GATA1_19941826_ChIP-Seq_K562_Human | 1.92261485 |
21 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.88633787 |
22 | MYC_22102868_ChIP-Seq_BL_Human | 1.85623835 |
23 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.84076490 |
24 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.83271947 |
25 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.82266232 |
26 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.80410177 |
27 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.79824800 |
28 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.76995232 |
29 | MAF_26560356_Chip-Seq_TH1_Human | 1.72647028 |
30 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.71209914 |
31 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.70601194 |
32 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.68453234 |
33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.67165019 |
34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.64556670 |
35 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.61347159 |
36 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.60544461 |
37 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.59245091 |
38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.59243044 |
39 | GATA2_19941826_ChIP-Seq_K562_Human | 1.54271242 |
40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.52610608 |
41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.52511178 |
42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.52122795 |
43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.48466269 |
44 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.46179708 |
45 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.45282794 |
46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.44544204 |
47 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.44084656 |
48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.43318407 |
49 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.43247841 |
50 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.43093191 |
51 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.41972356 |
52 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.41166164 |
53 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.39923044 |
54 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.39759672 |
55 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.38902710 |
56 | MYB_26560356_Chip-Seq_TH2_Human | 1.37654095 |
57 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37523992 |
58 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.37143443 |
59 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.36050762 |
60 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.35736867 |
61 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33052045 |
62 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.32146750 |
63 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31147693 |
64 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30663699 |
65 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.30599275 |
66 | KDM2B_26808549_Chip-Seq_K562_Human | 1.30558152 |
67 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.27808352 |
68 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27511529 |
69 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.26719652 |
70 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25936284 |
71 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.25220094 |
72 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.25112689 |
73 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23640721 |
74 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.23130127 |
75 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20864253 |
76 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.20854906 |
77 | MYB_26560356_Chip-Seq_TH1_Human | 1.20663287 |
78 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.19858561 |
79 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.18978199 |
80 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.18784054 |
81 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.15978105 |
82 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15909864 |
83 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14488155 |
84 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14474144 |
85 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.14389358 |
86 | P68_20966046_ChIP-Seq_HELA_Human | 1.13665092 |
87 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.13614884 |
88 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.13392119 |
89 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.12969489 |
90 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.11925539 |
91 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.11167770 |
92 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.11101797 |
93 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.10967485 |
94 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.10218218 |
95 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10190762 |
96 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.10086111 |
97 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09126252 |
98 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.09098799 |
99 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.09098799 |
100 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08602186 |
101 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.08339507 |
102 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.07819922 |
103 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07044994 |
104 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05882037 |
105 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.05700088 |
106 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05089660 |
107 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.04492477 |
108 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03992004 |
109 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03703451 |
110 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.03668685 |
111 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.02168036 |
112 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.02054370 |
113 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.00820167 |
114 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.00523569 |
115 | * MAF_26560356_Chip-Seq_TH2_Human | 0.99585304 |
116 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99196224 |
117 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99144354 |
118 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99085060 |
119 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98693142 |
120 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.98028456 |
121 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97892682 |
122 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.97806367 |
123 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97108683 |
124 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.96601458 |
125 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.96218296 |
126 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.95951515 |
127 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95820227 |
128 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.95489324 |
129 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.95301441 |
130 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94188066 |
131 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92968941 |
132 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.91720676 |
133 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90560886 |
134 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.90223899 |
135 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.89999820 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005451_abnormal_body_composition | 3.37584406 |
2 | MP0004510_myositis | 3.00189396 |
3 | MP0000685_abnormal_immune_system | 2.86057789 |
4 | MP0003303_peritoneal_inflammation | 2.69894734 |
5 | MP0001835_abnormal_antigen_presentation | 2.64128803 |
6 | MP0003300_gastrointestinal_ulcer | 2.59481642 |
7 | MP0003191_abnormal_cellular_cholesterol | 2.51365454 |
8 | MP0005387_immune_system_phenotype | 2.44026539 |
9 | MP0001790_abnormal_immune_system | 2.44026539 |
10 | MP0010234_abnormal_vibrissa_follicle | 2.37527046 |
11 | MP0004947_skin_inflammation | 2.21004994 |
12 | MP0001873_stomach_inflammation | 2.18962212 |
13 | MP0002166_altered_tumor_susceptibility | 2.13615285 |
14 | MP0001800_abnormal_humoral_immune | 2.11214304 |
15 | MP0003436_decreased_susceptibility_to | 2.09212860 |
16 | MP0003656_abnormal_erythrocyte_physiolo | 1.99786194 |
17 | MP0005671_abnormal_response_to | 1.99293538 |
18 | MP0008438_abnormal_cutaneous_collagen | 1.99244875 |
19 | MP0008961_abnormal_basal_metabolism | 1.98640728 |
20 | MP0005464_abnormal_platelet_physiology | 1.98372466 |
21 | MP0005025_abnormal_response_to | 1.93179991 |
22 | MP0000858_altered_metastatic_potential | 1.92061940 |
23 | MP0003453_abnormal_keratinocyte_physiol | 1.88573066 |
24 | MP0002822_catalepsy | 1.84666717 |
25 | MP0002452_abnormal_antigen_presenting | 1.80980876 |
26 | MP0005000_abnormal_immune_tolerance | 1.80831239 |
27 | MP0004147_increased_porphyrin_level | 1.80819104 |
28 | MP0009785_altered_susceptibility_to | 1.73630305 |
29 | MP0002723_abnormal_immune_serum | 1.73608368 |
30 | MP0008260_abnormal_autophagy | 1.70711831 |
31 | MP0001819_abnormal_immune_cell | 1.68949655 |
32 | MP0005167_abnormal_blood-brain_barrier | 1.68291039 |
33 | MP0002420_abnormal_adaptive_immunity | 1.67366035 |
34 | MP0005409_darkened_coat_color | 1.65713111 |
35 | MP0000569_abnormal_digit_pigmentation | 1.65160607 |
36 | MP0003866_abnormal_defecation | 1.63196315 |
37 | MP0010155_abnormal_intestine_physiology | 1.60059314 |
38 | MP0004185_abnormal_adipocyte_glucose | 1.59300592 |
39 | MP0002419_abnormal_innate_immunity | 1.58828064 |
40 | MP0004130_abnormal_muscle_cell | 1.54657454 |
41 | MP0006082_CNS_inflammation | 1.52888000 |
42 | MP0001849_ear_inflammation | 1.52466427 |
43 | MP0009278_abnormal_bone_marrow | 1.51519048 |
44 | MP0003045_fibrosis | 1.49359363 |
45 | MP0002006_tumorigenesis | 1.47819709 |
46 | MP0002398_abnormal_bone_marrow | 1.46628373 |
47 | MP0003705_abnormal_hypodermis_morpholog | 1.43895294 |
48 | MP0005083_abnormal_biliary_tract | 1.42179682 |
49 | MP0002837_dystrophic_cardiac_calcinosis | 1.41426400 |
50 | MP0009333_abnormal_splenocyte_physiolog | 1.39818550 |
51 | MP0003763_abnormal_thymus_physiology | 1.36094060 |
52 | MP0000678_abnormal_parathyroid_gland | 1.33184646 |
53 | MP0004858_abnormal_nervous_system | 1.32975233 |
54 | MP0005310_abnormal_salivary_gland | 1.31918817 |
55 | MP0002148_abnormal_hypersensitivity_rea | 1.31837492 |
56 | MP0003183_abnormal_peptide_metabolism | 1.31572081 |
57 | MP0000716_abnormal_immune_system | 1.29883729 |
58 | MP0010307_abnormal_tumor_latency | 1.29637933 |
59 | MP0000604_amyloidosis | 1.28718234 |
60 | MP0001348_abnormal_lacrimal_gland | 1.28478655 |
61 | MP0010352_gastrointestinal_tract_polyps | 1.25907613 |
62 | MP0004233_abnormal_muscle_weight | 1.24538205 |
63 | MP0005666_abnormal_adipose_tissue | 1.24388177 |
64 | MP0005670_abnormal_white_adipose | 1.23311032 |
65 | MP0003172_abnormal_lysosome_physiology | 1.22835139 |
66 | MP0000751_myopathy | 1.22548161 |
67 | MP0005023_abnormal_wound_healing | 1.21805485 |
68 | MP0003075_altered_response_to | 1.20345250 |
69 | MP0002405_respiratory_system_inflammati | 1.18187418 |
70 | MP0002138_abnormal_hepatobiliary_system | 1.16072560 |
71 | MP0001845_abnormal_inflammatory_respons | 1.15808623 |
72 | MP0005166_decreased_susceptibility_to | 1.12543267 |
73 | MP0002877_abnormal_melanocyte_morpholog | 1.12276956 |
74 | MP0004084_abnormal_cardiac_muscle | 1.11108416 |
75 | MP0009840_abnormal_foam_cell | 1.10966742 |
76 | MP0002132_abnormal_respiratory_system | 1.09654982 |
77 | MP0001666_abnormal_nutrient_absorption | 1.09317283 |
78 | MP0001533_abnormal_skeleton_physiology | 1.07880400 |
79 | MP0002429_abnormal_blood_cell | 1.07403217 |
80 | MP0000689_abnormal_spleen_morphology | 1.07032500 |
81 | MP0005058_abnormal_lysosome_morphology | 1.05207308 |
82 | MP0005397_hematopoietic_system_phenotyp | 1.05133341 |
83 | MP0001545_abnormal_hematopoietic_system | 1.05133341 |
84 | MP0009931_abnormal_skin_appearance | 1.04885292 |
85 | MP0002722_abnormal_immune_system | 1.04784009 |
86 | MP0003252_abnormal_bile_duct | 1.04320662 |
87 | MP0008469_abnormal_protein_level | 1.02306973 |
88 | MP0002998_abnormal_bone_remodeling | 1.01370288 |
89 | MP0003111_abnormal_nucleus_morphology | 1.00544876 |
90 | MP0000343_altered_response_to | 0.99955969 |
91 | MP0003566_abnormal_cell_adhesion | 0.99757339 |
92 | MP0003724_increased_susceptibility_to | 0.99274004 |
93 | MP0003828_pulmonary_edema | 0.98969474 |
94 | MP0005501_abnormal_skin_physiology | 0.98724581 |
95 | MP0000609_abnormal_liver_physiology | 0.98500666 |
96 | MP0005621_abnormal_cell_physiology | 0.98340448 |
97 | MP0004264_abnormal_extraembryonic_tissu | 0.97727623 |
98 | MP0004036_abnormal_muscle_relaxation | 0.96561862 |
99 | MP0002796_impaired_skin_barrier | 0.95872813 |
100 | MP0010329_abnormal_lipoprotein_level | 0.94858979 |
101 | MP0005076_abnormal_cell_differentiation | 0.94047473 |
102 | MP0004808_abnormal_hematopoietic_stem | 0.93989828 |
103 | MP0002971_abnormal_brown_adipose | 0.93426238 |
104 | MP0000015_abnormal_ear_pigmentation | 0.93005801 |
105 | MP0005360_urolithiasis | 0.90323282 |
106 | MP0005164_abnormal_response_to | 0.89518579 |
107 | MP0003950_abnormal_plasma_membrane | 0.89451469 |
108 | MP0000003_abnormal_adipose_tissue | 0.89135145 |
109 | MP0004087_abnormal_muscle_fiber | 0.88994014 |
110 | MP0009764_decreased_sensitivity_to | 0.88392944 |
111 | MP0001663_abnormal_digestive_system | 0.87989803 |
112 | MP0005375_adipose_tissue_phenotype | 0.87609829 |
113 | MP0002928_abnormal_bile_duct | 0.86575066 |
114 | MP0003329_amyloid_beta_deposits | 0.86007229 |
115 | MP0003091_abnormal_cell_migration | 0.85911978 |
116 | MP0002060_abnormal_skin_morphology | 0.85672640 |
117 | MP0001851_eye_inflammation | 0.85478857 |
118 | MP0004381_abnormal_hair_follicle | 0.85102172 |
119 | MP0008004_abnormal_stomach_pH | 0.84171611 |
120 | MP0008775_abnormal_heart_ventricle | 0.83359925 |
121 | MP0002254_reproductive_system_inflammat | 0.81341590 |
122 | MP0000767_abnormal_smooth_muscle | 0.81153884 |
123 | MP0004272_abnormal_basement_membrane | 0.80355652 |
124 | MP0002086_abnormal_extraembryonic_tissu | 0.79874499 |
125 | MP0003448_altered_tumor_morphology | 0.78790944 |
126 | MP0001765_abnormal_ion_homeostasis | 0.76578605 |
127 | MP0000703_abnormal_thymus_morphology | 0.76395990 |
128 | MP0010630_abnormal_cardiac_muscle | 0.76259951 |
129 | MP0001915_intracranial_hemorrhage | 0.75393035 |
130 | MP0005174_abnormal_tail_pigmentation | 0.73988809 |
131 | MP0001730_embryonic_growth_arrest | 0.73381764 |
132 | MP0002396_abnormal_hematopoietic_system | 0.73286503 |
133 | MP0004145_abnormal_muscle_electrophysio | 0.72706402 |
134 | MP0003795_abnormal_bone_structure | 0.72185266 |
135 | MP0001216_abnormal_epidermal_layer | 0.71652270 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Polycythemia (HP:0001901) | 3.90964418 |
2 | Nasal polyposis (HP:0100582) | 3.23234350 |
3 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.22559112 |
4 | Cholecystitis (HP:0001082) | 3.15609527 |
5 | Abnormal gallbladder physiology (HP:0012438) | 3.15609527 |
6 | Colitis (HP:0002583) | 3.13187350 |
7 | Abnormality of the nasal mucosa (HP:0000433) | 3.08280821 |
8 | Eczematoid dermatitis (HP:0000976) | 3.01941051 |
9 | Aortic aneurysm (HP:0004942) | 2.98450581 |
10 | Autoimmune thrombocytopenia (HP:0001973) | 2.95792858 |
11 | Inflammation of the large intestine (HP:0002037) | 2.89723059 |
12 | Abnormality of the fingertips (HP:0001211) | 2.89206889 |
13 | Poikilocytosis (HP:0004447) | 2.86257200 |
14 | Menorrhagia (HP:0000132) | 2.83629485 |
15 | Gastrointestinal inflammation (HP:0004386) | 2.81337726 |
16 | Recurrent fungal infections (HP:0002841) | 2.80114487 |
17 | Chronic otitis media (HP:0000389) | 2.76182751 |
18 | Recurrent viral infections (HP:0004429) | 2.68732973 |
19 | Hypertensive crisis (HP:0100735) | 2.67748861 |
20 | Ankyloglossia (HP:0010296) | 2.63689813 |
21 | Protrusio acetabuli (HP:0003179) | 2.54118147 |
22 | Recurrent bacterial skin infections (HP:0005406) | 2.53376170 |
23 | Hyperacusis (HP:0010780) | 2.52541507 |
24 | Heterotopia (HP:0002282) | 2.51975571 |
25 | Reticulocytosis (HP:0001923) | 2.50738636 |
26 | Disproportionate tall stature (HP:0001519) | 2.50631468 |
27 | Pustule (HP:0200039) | 2.50375136 |
28 | Macroorchidism (HP:0000053) | 2.50123581 |
29 | Abnormal platelet volume (HP:0011876) | 2.49066067 |
30 | Recurrent abscess formation (HP:0002722) | 2.48432037 |
31 | Increased IgE level (HP:0003212) | 2.47495861 |
32 | Petechiae (HP:0000967) | 2.44939717 |
33 | Increased mean platelet volume (HP:0011877) | 2.42189627 |
34 | Recurrent bronchitis (HP:0002837) | 2.41980624 |
35 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.38226457 |
36 | Acanthocytosis (HP:0001927) | 2.35992006 |
37 | Abnormality of reticulocytes (HP:0004312) | 2.33856712 |
38 | Broad face (HP:0000283) | 2.31081672 |
39 | Cerebral aneurysm (HP:0004944) | 2.28889584 |
40 | Abnormality of oral frenula (HP:0000190) | 2.28428127 |
41 | Hematochezia (HP:0002573) | 2.27289686 |
42 | T lymphocytopenia (HP:0005403) | 2.26852328 |
43 | Hyporeflexia of lower limbs (HP:0002600) | 2.25767535 |
44 | Cervical subluxation (HP:0003308) | 2.25623382 |
45 | Purpura (HP:0000979) | 2.25590988 |
46 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.25279896 |
47 | Cellulitis (HP:0100658) | 2.24454661 |
48 | Gingival bleeding (HP:0000225) | 2.24408342 |
49 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.24382919 |
50 | Postural instability (HP:0002172) | 2.21945949 |
51 | Increased cerebral lipofuscin (HP:0011813) | 2.21895741 |
52 | Premature rupture of membranes (HP:0001788) | 2.21740213 |
53 | Abnormal hemoglobin (HP:0011902) | 2.20911768 |
54 | Ureteral stenosis (HP:0000071) | 2.20117489 |
55 | Abnormality of T cell number (HP:0011839) | 2.19429060 |
56 | Asymmetric septal hypertrophy (HP:0001670) | 2.17350312 |
57 | Supranuclear gaze palsy (HP:0000605) | 2.12945617 |
58 | Sensorimotor neuropathy (HP:0007141) | 2.12458778 |
59 | Emphysema (HP:0002097) | 2.11779723 |
60 | Exercise-induced myalgia (HP:0003738) | 2.09532187 |
61 | Prolonged bleeding time (HP:0003010) | 2.09056163 |
62 | Cupped ribs (HP:0000887) | 2.09012627 |
63 | Dysostosis multiplex (HP:0000943) | 2.08405951 |
64 | Ureteral obstruction (HP:0006000) | 2.07387049 |
65 | Gastrointestinal stroma tumor (HP:0100723) | 2.06728006 |
66 | Fatigue (HP:0012378) | 2.06142283 |
67 | Hyperthyroidism (HP:0000836) | 2.05373748 |
68 | Truncus arteriosus (HP:0001660) | 2.04821723 |
69 | Verrucae (HP:0200043) | 2.04052854 |
70 | Papilloma (HP:0012740) | 2.04052854 |
71 | Vasculitis (HP:0002633) | 2.03797106 |
72 | Upper limb muscle weakness (HP:0003484) | 2.03548725 |
73 | Frequent falls (HP:0002359) | 2.03058530 |
74 | Spontaneous hematomas (HP:0007420) | 2.02499434 |
75 | Chest pain (HP:0100749) | 2.02432985 |
76 | Myocardial infarction (HP:0001658) | 2.01999122 |
77 | Flat acetabular roof (HP:0003180) | 1.99082706 |
78 | Upper limb amyotrophy (HP:0009129) | 1.98604496 |
79 | Distal upper limb amyotrophy (HP:0007149) | 1.98604496 |
80 | Aneurysm (HP:0002617) | 1.98184685 |
81 | Right ventricular cardiomyopathy (HP:0011663) | 1.97835293 |
82 | Increased serum ferritin (HP:0003281) | 1.97437867 |
83 | Bowel incontinence (HP:0002607) | 1.96504306 |
84 | Interstitial pulmonary disease (HP:0006530) | 1.94629445 |
85 | Dysmetric saccades (HP:0000641) | 1.94120691 |
86 | Recurrent skin infections (HP:0001581) | 1.93357764 |
87 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.92739648 |
88 | Recurrent cutaneous fungal infections (HP:0011370) | 1.92739648 |
89 | Abnormal large intestine physiology (HP:0012700) | 1.91375372 |
90 | Dilatation of the ascending aorta (HP:0005111) | 1.90875236 |
91 | Facial diplegia (HP:0001349) | 1.90348036 |
92 | Ileus (HP:0002595) | 1.90005352 |
93 | Vertebral compression fractures (HP:0002953) | 1.89790808 |
94 | Abnormal gallbladder morphology (HP:0012437) | 1.89488591 |
95 | Chronic obstructive pulmonary disease (HP:0006510) | 1.88882771 |
96 | Obstructive lung disease (HP:0006536) | 1.88882771 |
97 | Agammaglobulinemia (HP:0004432) | 1.88861569 |
98 | Arterial thrombosis (HP:0004420) | 1.88773937 |
99 | Gingivitis (HP:0000230) | 1.88084229 |
100 | Epistaxis (HP:0000421) | 1.87665510 |
101 | Hemorrhage of the eye (HP:0011885) | 1.87565905 |
102 | Myositis (HP:0100614) | 1.87134477 |
103 | Obstructive sleep apnea (HP:0002870) | 1.86490912 |
104 | Broad metatarsal (HP:0001783) | 1.85963548 |
105 | Difficulty running (HP:0009046) | 1.84791641 |
106 | Hypochromic anemia (HP:0001931) | 1.82884265 |
107 | Impaired platelet aggregation (HP:0003540) | 1.82254528 |
108 | Abnormal platelet function (HP:0011869) | 1.82254528 |
109 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.82074637 |
110 | Stomatitis (HP:0010280) | 1.81397624 |
111 | Lower limb amyotrophy (HP:0007210) | 1.80962447 |
112 | Hypoparathyroidism (HP:0000829) | 1.80451834 |
113 | Abnormality of nail color (HP:0100643) | 1.79912293 |
114 | Cholelithiasis (HP:0001081) | 1.79599472 |
115 | Distal lower limb amyotrophy (HP:0008944) | 1.79473915 |
116 | Periodontitis (HP:0000704) | 1.78957575 |
117 | Long toe (HP:0010511) | 1.76991017 |
118 | Sudden death (HP:0001699) | 1.76893360 |
119 | Decreased motor nerve conduction velocity (HP:0003431) | 1.76195741 |
120 | Mediastinal lymphadenopathy (HP:0100721) | 1.75812702 |
121 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.75609665 |
122 | Blue sclerae (HP:0000592) | 1.75233968 |
123 | Abnormality of iron homeostasis (HP:0011031) | 1.74252114 |
124 | Gastrointestinal infarctions (HP:0005244) | 1.73932970 |
125 | Loss of speech (HP:0002371) | 1.73518718 |
126 | Striae distensae (HP:0001065) | 1.72970937 |
127 | Abnormality of the thoracic spine (HP:0100711) | 1.72598071 |
128 | Abnormality of T cells (HP:0002843) | 1.72426293 |
129 | Easy fatigability (HP:0003388) | 1.71369498 |
130 | Biconcave vertebral bodies (HP:0004586) | 1.70203360 |
131 | Long palpebral fissure (HP:0000637) | 1.69834708 |
132 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.69233601 |
133 | Ulnar bowing (HP:0003031) | 1.68602434 |
134 | Restrictive lung disease (HP:0002091) | 1.68376777 |
135 | Bruising susceptibility (HP:0000978) | 1.68350093 |
136 | Arterial tortuosity (HP:0005116) | 1.67666027 |
137 | Atelectasis (HP:0100750) | 1.67580424 |
138 | Autoimmune hemolytic anemia (HP:0001890) | 1.66217454 |
139 | Chronic diarrhea (HP:0002028) | 1.65798029 |
140 | Hypertriglyceridemia (HP:0002155) | 1.65699581 |
141 | Vacuolated lymphocytes (HP:0001922) | 1.65169242 |
142 | Abnormality of the gallbladder (HP:0005264) | 1.65149616 |
143 | Abnormality of macrophages (HP:0004311) | 1.62795798 |
144 | Insomnia (HP:0100785) | 1.62545638 |
145 | Thin bony cortex (HP:0002753) | 1.62114790 |
146 | Seborrheic dermatitis (HP:0001051) | 1.61907496 |
147 | Venous abnormality (HP:0002624) | 1.61861868 |
148 | Ovoid vertebral bodies (HP:0003300) | 1.61855207 |
149 | Meningitis (HP:0001287) | 1.61294420 |
150 | J-shaped sella turcica (HP:0002680) | 1.60953761 |
151 | Fragile skin (HP:0001030) | 1.60941821 |
152 | Gastrointestinal dysmotility (HP:0002579) | 1.60485812 |
153 | Chronic sinusitis (HP:0011109) | 1.59799706 |
154 | Sparse lateral eyebrow (HP:0005338) | 1.58636320 |
155 | Metaphyseal cupping (HP:0003021) | 1.58079132 |
156 | Mucopolysacchariduria (HP:0008155) | 1.58035257 |
157 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.58035257 |
158 | Panhypogammaglobulinemia (HP:0003139) | 1.57782132 |
159 | Increased connective tissue (HP:0009025) | 1.57110781 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TBK1 | 3.94772719 |
2 | IKBKE | 3.15248401 |
3 | ERN1 | 2.79246814 |
4 | MAP4K1 | 2.75527076 |
5 | PRPF4B | 2.72026905 |
6 | TRIB3 | 2.67989063 |
7 | PKN2 | 2.20034419 |
8 | TTN | 2.17377704 |
9 | TYK2 | 2.07535806 |
10 | GRK6 | 2.06905584 |
11 | MAP3K10 | 2.05737162 |
12 | EEF2K | 1.94606290 |
13 | MAP3K13 | 1.92948412 |
14 | RIPK4 | 1.91707817 |
15 | SIK2 | 1.88544855 |
16 | JAK1 | 1.85484081 |
17 | MAP3K14 | 1.76186787 |
18 | JAK3 | 1.75868379 |
19 | RIPK1 | 1.69709095 |
20 | SMG1 | 1.69677653 |
21 | FGFR4 | 1.66600139 |
22 | EIF2AK1 | 1.62231723 |
23 | PTK6 | 1.55544702 |
24 | EPHB1 | 1.55500549 |
25 | DMPK | 1.54957994 |
26 | MAP3K7 | 1.54138537 |
27 | TAOK1 | 1.50896422 |
28 | IKBKB | 1.45523487 |
29 | PDPK1 | 1.41642309 |
30 | TAOK3 | 1.39577055 |
31 | MAP3K3 | 1.38121108 |
32 | TGFBR2 | 1.36445723 |
33 | PDK1 | 1.35531403 |
34 | CAMK1G | 1.31910252 |
35 | TAOK2 | 1.28263804 |
36 | FGFR3 | 1.27427644 |
37 | BLK | 1.23202819 |
38 | KIT | 1.22750891 |
39 | MAP3K6 | 1.20688023 |
40 | SIK1 | 1.18909292 |
41 | ZAP70 | 1.17945060 |
42 | CAMK1D | 1.15769393 |
43 | SYK | 1.14166058 |
44 | JAK2 | 1.08791783 |
45 | CSK | 1.06388831 |
46 | HCK | 1.04233864 |
47 | EPHA2 | 0.98405736 |
48 | STK10 | 0.97863793 |
49 | SGK3 | 0.93526964 |
50 | KSR2 | 0.88606115 |
51 | LRRK2 | 0.86176719 |
52 | PRKCH | 0.84620925 |
53 | MARK2 | 0.83653504 |
54 | MAP3K8 | 0.83271879 |
55 | ITK | 0.82739918 |
56 | FES | 0.81723116 |
57 | MST4 | 0.78292595 |
58 | DDR2 | 0.76922038 |
59 | NME2 | 0.76615225 |
60 | SIK3 | 0.76355969 |
61 | PIK3CA | 0.76308721 |
62 | PAK4 | 0.76227873 |
63 | MAP2K3 | 0.75753155 |
64 | TYRO3 | 0.75498314 |
65 | LCK | 0.75033492 |
66 | PIM1 | 0.74744403 |
67 | PRKD1 | 0.74641070 |
68 | BMPR2 | 0.74395872 |
69 | MET | 0.74187259 |
70 | RET | 0.73796676 |
71 | BTK | 0.73633826 |
72 | CDK9 | 0.72883168 |
73 | PRKG2 | 0.72479926 |
74 | CDK12 | 0.72469298 |
75 | MAPK12 | 0.70195463 |
76 | DAPK2 | 0.70165980 |
77 | LMTK2 | 0.68894470 |
78 | KSR1 | 0.68339004 |
79 | MAP3K11 | 0.66000468 |
80 | CHUK | 0.65476068 |
81 | MAPK11 | 0.65473727 |
82 | TXK | 0.65331426 |
83 | CLK1 | 0.65275311 |
84 | PRKAA2 | 0.64542385 |
85 | RPS6KL1 | 0.63241112 |
86 | RPS6KC1 | 0.63241112 |
87 | BMX | 0.62592463 |
88 | MAP3K2 | 0.62109111 |
89 | HIPK2 | 0.61340020 |
90 | CDK6 | 0.60743530 |
91 | STK4 | 0.60567314 |
92 | MATK | 0.60073296 |
93 | PKN1 | 0.59951679 |
94 | RPS6KA2 | 0.56793740 |
95 | PRKCQ | 0.56580758 |
96 | MAP3K9 | 0.55608488 |
97 | PDGFRB | 0.55184698 |
98 | IRAK2 | 0.55082902 |
99 | MAP3K1 | 0.54902325 |
100 | NTRK1 | 0.54410506 |
101 | CDK4 | 0.54066215 |
102 | PRKD2 | 0.50548876 |
103 | RAF1 | 0.50388390 |
104 | ICK | 0.49578465 |
105 | CDC42BPA | 0.49536647 |
106 | LATS2 | 0.48574599 |
107 | PTK2B | 0.47948962 |
108 | MAP2K6 | 0.46396256 |
109 | MST1R | 0.46394461 |
110 | STK11 | 0.46117491 |
111 | IRAK3 | 0.45372494 |
112 | RPS6KA6 | 0.45294028 |
113 | YES1 | 0.45240911 |
114 | NEK2 | 0.45199802 |
115 | CSF1R | 0.45037455 |
116 | WNK1 | 0.43634186 |
117 | DYRK1B | 0.43177807 |
118 | PTK2 | 0.43128525 |
119 | FYN | 0.43052451 |
120 | MOS | 0.42899100 |
121 | CAMKK1 | 0.42171924 |
122 | EPHA3 | 0.41845644 |
123 | MAP2K1 | 0.41345356 |
124 | MTOR | 0.40895583 |
125 | MELK | 0.40170232 |
126 | MARK3 | 0.39565602 |
127 | TRPM7 | 0.39407223 |
128 | FGR | 0.38860925 |
129 | PDGFRA | 0.38633055 |
130 | IRAK4 | 0.38519290 |
131 | STK38 | 0.38512541 |
132 | IGF1R | 0.35849381 |
133 | SRC | 0.35347025 |
Rank | Gene Set | Z-score |
---|---|---|
1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.78224108 |
2 | Bladder cancer_Homo sapiens_hsa05219 | 1.77097624 |
3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.71715657 |
4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.65154900 |
5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.54839649 |
6 | Measles_Homo sapiens_hsa05162 | 1.54366677 |
7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.53424899 |
8 | Leishmaniasis_Homo sapiens_hsa05140 | 1.51693449 |
9 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.50358941 |
10 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.42926726 |
11 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.32822395 |
12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.32544418 |
13 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.30406261 |
14 | Influenza A_Homo sapiens_hsa05164 | 1.30103461 |
15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29364207 |
16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.28421943 |
17 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.26693210 |
18 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.26617659 |
19 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.25122068 |
20 | ABC transporters_Homo sapiens_hsa02010 | 1.24650850 |
21 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.23776849 |
22 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.23100392 |
23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22783492 |
24 | Insulin resistance_Homo sapiens_hsa04931 | 1.21112786 |
25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.17905079 |
26 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.16253754 |
27 | Thyroid cancer_Homo sapiens_hsa05216 | 1.15777120 |
28 | Pertussis_Homo sapiens_hsa05133 | 1.14903902 |
29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.13156461 |
30 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.13131507 |
31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.12399217 |
32 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.12091963 |
33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.11803472 |
34 | Platelet activation_Homo sapiens_hsa04611 | 1.11757467 |
35 | Endometrial cancer_Homo sapiens_hsa05213 | 1.11700185 |
36 | Hepatitis C_Homo sapiens_hsa05160 | 1.10473388 |
37 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.09003558 |
38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.07619676 |
39 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.07475026 |
40 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.07410306 |
41 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.06436003 |
42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.04983853 |
43 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.04476680 |
44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.02743360 |
45 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01724497 |
46 | Tuberculosis_Homo sapiens_hsa05152 | 1.01692310 |
47 | Prostate cancer_Homo sapiens_hsa05215 | 1.00724110 |
48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.00043290 |
49 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.95726651 |
50 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.95642212 |
51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95380151 |
52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.95109860 |
53 | Shigellosis_Homo sapiens_hsa05131 | 0.94652568 |
54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93980932 |
55 | Prion diseases_Homo sapiens_hsa05020 | 0.91911853 |
56 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.91502164 |
57 | Bile secretion_Homo sapiens_hsa04976 | 0.91321126 |
58 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.90227154 |
59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89693620 |
60 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88596316 |
61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87908966 |
62 | Salivary secretion_Homo sapiens_hsa04970 | 0.87383708 |
63 | Hepatitis B_Homo sapiens_hsa05161 | 0.84898100 |
64 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.84386528 |
65 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.83986752 |
66 | Lysosome_Homo sapiens_hsa04142 | 0.82809746 |
67 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.82082605 |
68 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.81949644 |
69 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81486568 |
70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81390512 |
71 | Lysine degradation_Homo sapiens_hsa00310 | 0.80614287 |
72 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.79715430 |
73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.78799705 |
74 | Renin secretion_Homo sapiens_hsa04924 | 0.78433128 |
75 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.78420908 |
76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78248989 |
77 | Malaria_Homo sapiens_hsa05144 | 0.77817623 |
78 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.77503038 |
79 | Mineral absorption_Homo sapiens_hsa04978 | 0.76009381 |
80 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.75075829 |
81 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.75014187 |
82 | Salmonella infection_Homo sapiens_hsa05132 | 0.73399118 |
83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.73261550 |
84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73095863 |
85 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.71875557 |
86 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.71078903 |
87 | Apoptosis_Homo sapiens_hsa04210 | 0.70719311 |
88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70563193 |
89 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.70265164 |
90 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.70072811 |
91 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.69605875 |
92 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68752703 |
93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67458970 |
94 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.67300850 |
95 | Amoebiasis_Homo sapiens_hsa05146 | 0.67270505 |
96 | Endocytosis_Homo sapiens_hsa04144 | 0.66792326 |
97 | Legionellosis_Homo sapiens_hsa05134 | 0.66710322 |
98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66037333 |
99 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.65184342 |
100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65104495 |
101 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65083129 |
102 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64745972 |
103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.64635198 |
104 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.62753212 |
105 | Adherens junction_Homo sapiens_hsa04520 | 0.62017123 |
106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61370366 |
107 | Galactose metabolism_Homo sapiens_hsa00052 | 0.61052870 |
108 | Glioma_Homo sapiens_hsa05214 | 0.61052542 |
109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59693005 |
110 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.59143454 |
111 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.58986324 |
112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58790100 |
113 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58633773 |
114 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.57450196 |
115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.56476487 |
116 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56070479 |
117 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55204539 |
118 | Focal adhesion_Homo sapiens_hsa04510 | 0.54428419 |
119 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54266425 |
120 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.53672156 |
121 | Long-term potentiation_Homo sapiens_hsa04720 | 0.53475036 |
122 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.52409787 |
123 | Olfactory transduction_Homo sapiens_hsa04740 | 0.52205924 |
124 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.52191743 |
125 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.51837915 |
126 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.51607562 |
127 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51532932 |
128 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.51048923 |
129 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50650353 |
130 | Colorectal cancer_Homo sapiens_hsa05210 | 0.50137894 |
131 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49316294 |
132 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48685609 |
133 | Pathways in cancer_Homo sapiens_hsa05200 | 0.46939345 |
134 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46532726 |